StonvexLoading…
StonvexStonvexStonvexCore line items from PMCB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-4.34M | $-2.22M | $-848.30K | $-4.38M |
Net Income | $-15.03M | $-7.42M | $-8.36M | $30.66M |
EPS (Diluted) | $-2.41 | $-2.47 | $-1.23 | $3.19 |
Total Assets | $55.87M | $55.98M | $45.11M | $55.17M |
Total Liabilities | $16.47M | $19.42M | $1.52M | $3.28M |
Cash & Equivalents | $20.17M | $15.41M | $13.18M | $15.17M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 10.74M | 6.80M | 6.80M | 6.80M |